Multiple analysts updated their ratings and price targets for Exelixis, Inc., generally raising their price targets while maintaining existing ratings. This indicates a moderately positive sentiment shift among analysts, potentially leading to increased investor interest in the short term.
On October 30, 2026, TD Cowen, Barclays, and Truist Securities all raised their price targets for Exelixis, Inc., with TD Cowen maintaining a 'Buy' rating, Barclays an 'Equal-Weight', and Truist a 'Hold'. This collective upward revision in price targets, leading to an average 12-month target of $59.21, signals a more optimistic outlook from the analyst community on Exelixis' future performance. This is primarily positive for current EXEL shareholders and potential investors, as it suggests a higher perceived intrinsic value for the company. In the short term, this could generate positive momentum and increased trading volume for EXEL. Long-term implications depend on whether the company's fundamentals align with these raised expectations, with the key opportunity for traders being to capitalize on any immediate price appreciation driven by this analyst sentiment shift.